C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Xencor and UCLA Enter Collaboration to Discover and Develop Novel XmAb® Therapeutics

Friday, February 26, 2021

Xencor Inc a clinicalstage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases and UCLA Technology Development Group UCLA TDG

SHEPHERD Therapeutics and Mayo Clinic Announce Collaboration to Advance Research in Rhabdomyosarcoma Using SHEPHERD's Precision-Oncology Platform, DELVE

Friday, February 26, 2021

SHEPHERD Therapeutics a company dedicated to catalyzing lifesaving treatments for rare cancer patients announced a collaboration with the Mayo Clinic to advance research in rhabdomyosarcoma RMS a rare pediatric cancer with few treatment options

Daiichi Sankyo and LYSA-LYSARC-CALYM Enter Research Collaboration for Valemetostat in Patients with Relapsed/Refractory B-Cell Lymphoma

Thursday, February 25, 2021

Daiichi Sankyo Company Limited and LYSALYSARCCALYM announced that they have entered a strategic research collaboration to study valemetostat DS

QIAGEN and INOVIO Expand Collaboration to Develop NGS Companion Diagnostics for INOVIO's VGX-3100 for Advanced Cervical Dysplasia

Thursday, February 25, 2021

QIAGEN and INOVIO Pharmaceuticals gave announced the expansion of their partnership through a new framework agreement for the development of liquid biopsy companion diagnostic products based on NGS technology Next Generation Sequencing to complement...

Adaptive Biotechnologies Expands Collaboration with Labcorp to Increase Access to Growing Research and Clinical Diagnostic Portfolio

Wednesday, February 24, 2021

Adaptive Biotechnologies Corporation a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease

SIRION Biotech Announces Collaboration with Sanofi to Innovate Gene Therapy Treatments with Improved Adeno-Associated Virus Capsids

Wednesday, February 24, 2021

SIRION Biotech GmbH a world leader in viral vectorbased gene delivery technologies for gene cell therapy announced that it signed a license and collaboration agreement with Sanofi a global biopharmaceutical company

SunRock Biopharma and GenScript ProBio to develop new monoclonal antibody program

Tuesday, February 23, 2021

GenScript ProBio and SunRock Biopharma a company focused on developing cancertargeted antibody therapeutics announced a collaboration spanning preclinical discovery for largescale GMP manufacturing for SunRocks CCR therapeutic antibody candidates

Compugen Expands Clinical Collaboration Agreement with Bristol Myers Squibb with Phase 1b Combination Study of COM701 with Opdivo®

Tuesday, February 23, 2021

Compugen Ltd a clinicalstage cancer immunotherapy company and a leader in predictive target discovery announced the expansion of its clinical collaboration agreement with Bristol Myers Squibb

NMPA Approves Toripalimab in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma after Failure of at Least Two Lines of Prior Systemic Therapy

Monday, February 22, 2021

Junshi Biosciences a leading innovationdriven biopharmaceutical company dedicated to the discovery development and commercialization of novel therapies announced today that the National Medical Products Administration NMPA of China has granted a cond...

ForDoz Enters Contract Manufacturing Agreement for Oncology Liposomal Product with LipoMedix

Saturday, February 20, 2021

ForDoz Pharma has entered into an agreement with LipoMedix for manufacturing its lead compound pegylated liposomal Promitil PLMLP for a Phase clinical studyPromitils unique liposomal formulation is designed for selective delivery of the therapeutic...

Latest Issue
Get instant
access to our latest e-book
Saving Money, Saving Time In Pharma Operations